Galera Therapeutics (GRTX) Insider Trading & Ownership

$0.20
+0.02 (+9.58%)
(As of 12:53 PM ET)

Galera Therapeutics (NASDAQ:GRTX) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
6.90%
Number Of
Insiders Buying
(Last 3 Years)
4
Amount Of
Insider Buying
(Last 3 Years)
$444,950.00
Number Of
Insiders Selling
(Last 3 Years)
0
Get GRTX Insider Trade Alerts

Want to know when executives and insiders are buying or selling Galera Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

GRTX Insider Buying and Selling by Quarter

Galera Therapeutics Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
3/16/2023Mark BachledaInsiderBuy11,000$2.25$24,750.00  
3/13/2023Chris DegnanCFOBuy10,000$1.96$19,600.00  
3/10/2023Mel SorensenCEOBuy100,000$1.68$168,000.00  
12/17/2021Linda WestDirectorBuy20,000$2.74$54,800.00  
6/15/2021Linda WestDirectorBuy10,000$9.13$91,300.00  
6/2/2021Linda WestDirectorBuy10,000$8.65$86,500.00  
(Data available from 1/1/2013 forward)

GRTX Insider Trading Activity - Frequently Asked Questions

Who is on Galera Therapeutics's Insider Roster?

The list of insiders at Galera Therapeutics includes Chris Degnan, Linda West, Mark Bachleda, and Mel Sorensen. Learn more on insiders at GRTX.

What percentage of Galera Therapeutics stock is owned by insiders?

6.90% of Galera Therapeutics stock is owned by insiders. Learn more on GRTX's insider holdings.

Which Galera Therapeutics insiders have been buying company stock?

The following insiders have purchased GRTX shares in the last 24 months: Chris Degnan ($19,600.00), Mark Bachleda ($24,750.00), and Mel Sorensen ($168,000.00).

How much insider buying is happening at Galera Therapeutics?

Insiders have purchased a total of 121,000 GRTX shares in the last 24 months for a total of $212,350.00 bought.


More Insider Trading Tools from MarketBeat

This page (NASDAQ:GRTX) was last updated on 4/25/2024 by MarketBeat.com Staff

From Our Partners